Except they already did find significance so what are you talking about? Sample size only matters in regards to a treatment effect if you don't reach significance with narrow confidence intervals? They did reach in CHF and CLBP so mute point. In terms of generalisation of results 566 is pretty damn good and good enough for an FDA approval as history shows.
- Forums
- ASX - By Stock
- MSB
- Novartis - Heart Failure - Primary Endpoints
MSB
mesoblast limited
Add to My Watchlist
2.12%
!
$2.31

Novartis - Heart Failure - Primary Endpoints, page-52
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.31 |
Change
-0.050(2.12%) |
Mkt cap ! $2.956B |
Open | High | Low | Value | Volume |
$2.35 | $2.36 | $2.30 | $6.343M | 2.732M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 18304 | $2.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.32 | 30000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 2.310 |
5 | 13765 | 2.300 |
1 | 43668 | 2.290 |
10 | 46947 | 2.280 |
5 | 30700 | 2.270 |
Price($) | Vol. | No. |
---|---|---|
2.320 | 30000 | 1 |
2.340 | 3000 | 1 |
2.350 | 8500 | 2 |
2.360 | 1739 | 1 |
2.370 | 420 | 1 |
Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |